menu search

Umoja biopharma to present at the 2023 cell & gene meeting on the mesa

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) — Umoja Biopharma, Inc., a transformative immuno-oncology company creating off-the-shelf treatments for soli...

October 5, 2023, 6:30 pm

Be the match raises $1.1 million at annual gala

Funds raised support saving more lives through blood stem cell transplants MINNEAPOLIS, Oct. 05, 2023 (GLOBE NEWSWIRE) — On Saturday, September 30, ...

October 5, 2023, 1:18 pm

Perimeter medical imaging ai advances to next stage of grant funding program

Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) announced that it has been shortlisted in a grant funding process sponsored by the Advanced Resea...

October 5, 2023, 9:09 am

Novartis to present new oncology data at esmo 2023 demonstrating practice-changing innovation in advanced prostate and early breast cancer

Basel, October 5, 2023 — Novartis will present new data from 29 Novartis and investigator-led abstracts at the European Society for Medical Oncology...

October 5, 2023, 1:15 am

Verastem: signs of life for a beaten-down equity

Verastem is a biotechnology company focused on developing novel agents for solid tumors, with its main candidate being avutometinib. Avutometinib is b...

October 4, 2023, 9:00 pm

Revolution medicines to present new clinical data at major oncology conferences and host investor webcast

Interim Data to be Presented for RMC-6236 (RASMULTI(ON) Inhibitor) and RMC-6291 (RASG12C(ON) Inhibitor) Company to Host Investor Webcast Following ESM...

October 4, 2023, 8:05 pm

Black diamond therapeutics to present preclinical and clinical data at the aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology ...

October 4, 2023, 12:14 pm

Why invitae stock popped today

Late Friday, the U.S. FDA granted De Novo marketing authorization for the Invitae Common Hereditary cancers...

October 2, 2023, 4:20 pm

Actinium pharmaceuticals trickling down through 2023: are they flying under the radar?

Actinium is making radiolabeled antibodies for use in hematologic cancers. Previously reported phase 3 ...

September 15, 2023, 7:02 pm

Adaptive announces launch of epic integration for clonoseq®

The Adaptive-Epic integration will provide clinicians and patients with easier access to minimal residual disease (MRD) monitoring in blood ...

September 13, 2023, 11:30 am

Ispecimen expands provider network to enhance support for women’s health research

Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast cance...

September 13, 2023, 11:30 am

Why shares of crinetics pharmaceuticals are jumping monday

Crinetics focuses on treatments for rare endocrine-related diseases and cancers. The company had only $...

September 11, 2023, 12:57 pm

Plus therapeutics receives $1.9 million advance payment from cprit and plans to present at the cprit innovations in cancer prevention and research conference

AUSTIN, Texas, Sept. 11, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq:  PSTV ) (the “Company”), a clinical-stage pharmaceutical compa...

September 11, 2023, 7:00 am

Adding zymeworks to my value watchlist (initial buy rating)

Zymeworks is a biotech company focused on developing therapies for hard-to-treat cancers. Its lead prod...

September 11, 2023, 3:06 am

Hillstream biopharma to present at h.c. wainwright 25th annual global investment conference september 11-13

Management will present and hold virtual 1-on-1 meetings with institutional investors and analysts BRIDGEWATER, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) ...

September 8, 2023, 6:30 pm

Hillstream biopharma to present at h.c. wainwright 25th annual global investment conference september 11-13

BRIDGEWATER, N.J., Sept. 08, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology compa...

September 8, 2023, 2:30 pm

Microsoft teams up with paige on ai-powered cancer detection

Microsoft Corp (NASDAQ: MSFT) has partnered with Paige on the world's largest AI model for detecting cancer. Paige has a history of winning FDA approv...

September 7, 2023, 1:40 pm

Mustang bio to participate in upcoming september 2023 investor conferences

WORCESTER, Mass., Sept. 07, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focu...

September 7, 2023, 8:15 am

Cns pharmaceuticals (nasdaq: cnsp) to present at the h.c. wainwright 25th annual global investment conference

Live webcast presentation on Wednesday, September 13th at 10:30 AM ET HOUSTON, TX / ACCESSWIRE / September 5, 2023 / CNS Pharmaceuticals, Inc. (NASDAQ...

September 5, 2023, 8:45 am

Arvinas' potential in treating er+, her2- breast cancer

Arvinas focuses on protein degradation therapies, with current projects targeting breast and prostate cancers<...

September 4, 2023, 1:50 am


Search within

Pages Search Results: